THE global leader in  blood management solutions for our customers

2016 Press Releases

Webcast ImageWebcast
Q4 2016 Haemonetics Corporation Earnings Conference Call (Replay)
05/02/16 at 8:00 a.m. ET
Q4 2016 Haemonetics Corporation Earnings Conference Call
Monday, May 2, 2016 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Haemonetics Corporation Annual Investor and Analyst Meeting (Live)
05/10/16 at 9:30 a.m. ET
Haemonetics Corporation Annual Investor and Analyst Meeting
Tuesday, May 10, 2016 9:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2016 | 2015 | 2014 | 2013 | 2012
DateTitle 
May. 02, 2016Haemonetics Reports 4th Quarter Fiscal 2016 Revenue of $243 Million, Constant Currency Revenue Growth of 10% and 7% As Reported; Fiscal 2016 Revenue of $910 Million, Constant Currency Revenue Growth of 3% and Flat As Reported
BRAINTREE, Mass., May 2, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) reported fourth quarter fiscal 2016 revenue of $243.2 million, up 7%.  Revenue was up 10% over the fourth quarter of fiscal 2015 in constant currency, benefiting by 6.8% from the inclusion of a 53rd week.  The Company reported a GAAP net loss of $8.8 million or $0.17 per share in the fourth quarter of fiscal 2016. Exclusive of non-cash asset impairments, transformation, restructuring and deal amortization exp... 
Printer Friendly Version
Apr. 29, 2016Haemonetics Honored for Delivering 'World-Class' Customer Service
Receives Omega's prestigious NorthFace ScoreBoard Award(SM) for exceeding customer expectations BRAINTREE, Mass., April 29, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that it has received the NorthFace ScoreBoard AwardSM from Omega Management Group Corp. in recognition of achieving excellence in customer service and support in 2015. This marks the sixteenth consecutive year that Haemonetics has earned this high honor. Since 2000, the award has been presented annu... 
Printer Friendly Version
Apr. 14, 2016Haemonetics Announces CFO's Retirement
BRAINTREE, Mass., April 14, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Christopher Lindop, Chief Financial Officer and Executive Vice President, Business Development has announced his retirement from Haemonetics Corporation effective May 27, 2016.  The Company announced it will immediately begin a search for Mr. Lindop's successor. Mr. Lindop joined the Company in 2007 and has led the Company's finance, investor relations and business development activitie... 
Printer Friendly Version
Apr. 07, 2016Haemonetics Sets Date for 4th Quarter and Fiscal 2016 Earnings Release: May 2, 2016
BRAINTREE, Mass., April 7, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company will report its results for the fourth quarter and fiscal year 2016 on Monday, May 2, 2016 in a pre-market press release. As previously announced, the Company will provide its outlook for fiscal 2017 as part of a comprehensive review of its business franchise strategies at its annual investor day event on May 10, 2016. The Company will hold a webcast conference call with investors... 
Printer Friendly Version
Apr. 05, 2016Haemonetics Sets Date for Investor/Analyst Meeting - May 10, 2016
BRAINTREE, Mass., April 5, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that it will host its annual investor and analyst meeting on Tuesday, May 10th from 9:00am to 2:30pm at The State Room, 60 State Street in Boston, Massachusetts. The agenda for the meeting will include results of the Company's strategic review of its business franchise opportunities, fiscal 2017 guidance and longer-range financial indications. The meeting is open to analysts, shareholders,... 
Printer Friendly Version
Mar. 02, 2016Haemonetics to Present at the Raymond James 37th Annual Institutional Investors Conference
BRAINTREE, Mass., March 2, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Gerry Gould, Vice President – Investor Relations, will present at the Raymond James 37th Annual Institutional Investors Conference in Orlando, FL on Wednesday, March 9, 2016 at 7:30 am Eastern time.  The public may access Mr. Gould's presentation live via webcast at http://wsw.com/webcast/rj99/hae. Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative... 
Printer Friendly Version
Feb. 01, 2016Haemonetics Reports 3rd Quarter Fiscal 2016 Revenue of $233 Million, Constant Currency Revenue Growth of 4% and 1% As Reported
BRAINTREE, Mass., Feb. 1, 2016 /PRNewswire/ -- Revenue Growth Highlights The constant currency revenue increase in the third quarter included strong performance from identified growth drivers: 14% growth in Plasma disposables revenue 18% growth in Hemostasis Management (TEG®) disposables revenue 9% growth in Emerging Markets disposables revenue, ex-Russia Haemonetics Corporation (NYSE: HAE) reported third quarter fiscal 2016 revenue of $233.4 million, up 1%.  Revenue was up ... 
Printer Friendly Version
Jan. 07, 2016Haemonetics Sets Date for 3rd Quarter Fiscal 2016 Earnings Release: February 1, 2016
BRAINTREE, Mass., Jan. 7, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that the Company will report its results for the third quarter of fiscal year 2016 on Monday, February 1, 2016 in a pre-market press release.  The Company will hold a webcast conference call with investors and analysts to discuss and answer questions about the results at 8:00 am Eastern Time on February 1, 2016.  Webcast Link: http://edge.media-server.com/m/p/mieb5m8u Webcast replay will ... 
Printer Friendly Version